Enlivex Therapeutics Ltd (ENLV) stock has fallen -68.01% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ENLV stock a score of 30 out of a possible 100.
That rank is influenced by a short-term technical score of 7. ENLV's rank also includes a long-term technical score of 10.
ENLV has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on ENLV!
Enlivex Therapeutics Ltd (ENLV) stock has fallen -12.34% while the S&P 500 has gained 0.19% as of 1:27 PM on Monday, Oct 9. ENLV has fallen -$0.19 from the previous closing price of $1.54 on volume of 23,758 shares. Over the past year the S&P 500 is higher by 19.50% while ENLV has fallen -68.01%. ENLV lost -$1.63 per share in the over the last 12 months.
Click Here to get the full Stock Report for Enlivex Therapeutics Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
